C50 C18 C43 C19 C20
Conditions
Interventions
Group 1: Non-interventional observational study without intervention arms. The study comprises a linked secondary analysis of routine health insurance data from AOK Lower Saxony and data from the Clin
Sponsors
Medizinische Hochschule Hannover, Institut für Allgemeinmedizin und Palliativmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: AP1a: Oncological disease (breast cancer, colorectal cancer stage II and III, melanoma), first diagnosis between 2021 and 2023, insured by AOK, residence in Lower Saxony, adult age AP1b: Medical practice in primary care in Lower Saxony AP1c: Medical practice in ambulatory oncological care in Lower Saxony AP1d: Oncological disease with completed primary treatment, residence in Lower Saxony, physical and cognitive ability to participate in interviews AP2a: Expert in oncological follow-up care in Germany, e.g. healthcare professionals from outpatient and inpatient care, representatives of professional societies and associations, patient representatives, or representatives of self-help groups AP2b: Expert in oncological follow-up care in Germany, e.g. healthcare professionals from outpatient and inpatient care, representatives of professional societies and associations, patient representatives, or representatives of self-help groups
Exclusion criteria
Exclusion criteria: AP1a: None AP1b: Exclusive treatment of privately insured patients, insufficient German language proficiency for study participation AP1c: Exclusive treatment of privately insured patients, insufficient German language proficiency for study participation AP1d: Insufficient German language proficiency for study participation AP2a: Insufficient German language proficiency for study participation AP2b: Insufficient German language proficiency for study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Experiences, perspectives, barriers, and facilitators regarding general practitioner involvement in oncological follow-up care from the perspectives of general practitioners, oncological specialists, and patients. Outcomes will be assessed once during the study period within a cross-sectional design. Data collection will be performed using standardized online questionnaires (general practitioners and oncological specialists) and semi-structured problem-centered interviews (patients) | — |
Secondary
| Measure | Time frame |
|---|---|
| -Utilization of oncological follow-up services, involved physician groups, and adherence to recommended follow-up schemes; assessed once during the study period using quantitative secondary analysis of linked routine data from AOK Lower Saxony and the Clinical Cancer Registry of Lower Saxony. -Use and perceived usefulness of cancer survivorship care plans/passports; assessed once using standardized online questionnaires and qualitative interviews. -Interprofessional communication between general practitioners and oncological specialists; assessed once using standardized online questionnaires and qualitative interviews. -Consensus-based recommendations for enhanced general practitioner involvement in oncological follow-up care; developed in an expert workshop and finalized through a two- to three-round Delphi process. | — |
Countries
Germany
Contacts
Public ContactKatharina van Baal
Medizinische Hochschule Hannover
Outcome results
None listed